Clinical Trials Browser

Down Syndrome × Daunorubicin × Clear all

NCT07232134 2025-11-20

AML-DS-2025

Phase 3 Recruiting

Other hematologic neoplasm

Down Syndrome, Leukemia, Myeloid, Acute

NCT02521493 2025-08-01

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

Phase 3 Active not recruiting

280 enrolled 13 charts

MyeloidOther hematologic neoplasm

Down Syndrome, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute